Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Medtronic | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients admitted for coronary artery bypass surgery taking antiplatelet medicine have an increased risk for bleeding.
Present study aims to compare the platelet function in two patient groups using different types of heart-lung machine methods.
It is assumed that one of the methods is superior verified by sensitive methods of testing platelet function.
Taking antiplatelet medication before cardiac surgery increases the risk for bleeding.
The surgical procedure and the use of a heart-lung machine may disturb the function of platelets, why measures to protect the existing function of platelets are of prime concern.
The present study aims to compare how two types of heart-lung machine methods influence platelet function in two groups of patients.
The platelet function will be tested before, during and after surgery by the use of two independent methods.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CPB Low Dose | Experimental | Conduct of cardiopulmonary bypass using a low heparin dose verified by the activated clotting time at 250 s |
|
| CPB High Dose | Experimental | Conduct of cardiopulmonary bypass using a high heparin dose verified by the activated clotting time at 480 s |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CPB Low Dose | Procedure | Performing CPB with low dose heparin and coated equipment |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of platelet function following cardiopulmonary bypass using platelet aggregometry | Included aggregometry tests: Multiplate and Rotem Platelet | Test of platelet function will be analysed on arrival to the operating room, post cardiopulmonary bypass and on day 1 in the intensive care unit based on the area under the curve depited from the two employed aggremometers |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative bleeding | Blood loss 24 hrs post surgery | Postoperative bleeding 24 hrs |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ulf Näslund, MD PhD | Department of Publich Health and Clinical Medicin, Umeå University, Sweden | Principal Investigator |
| Magnus Hedström, MD | Heart Centre Umeå University Hospital Sweden | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Heart Centre Umeå University Hospital | Umeå | S-901 85 | Sweden |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26402229 | Background | Olsson A, Alfredsson J, Hakansson E, Svedjeholm R, Berglund J, Berg S. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass. Scand Cardiovasc J. 2016;50(1):58-63. doi: 10.3109/14017431.2015.1099720. Epub 2015 Oct 20. | |
| 25566711 | Background | Mishra PK, Thekkudan J, Sahajanandan R, Gravenor M, Lakshmanan S, Fayaz KM, Luckraz H. The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass grafting. Ann Card Anaesth. 2015 Jan-Mar;18(1):45-51. doi: 10.4103/0971-9784.148321. |
Not provided
Not provided
Data will be shared after reviewing final results after study completion at this site and through publication in a scientific journal.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001791 | Blood Platelet Disorders |
| D020141 | Hemostatic Disorders |
| ID | Term |
|---|---|
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| CPB High Dose |
| Procedure |
Performing CPB with high dose heparin and uncoated equipment |
|
| 10494777 | Background | Mollnes TE, Videm V, Christiansen D, Bergseth G, Riesenfeld J, Hovig T. Platelet compatibility of an artificial surface modified with functionally active heparin. Thromb Haemost. 1999 Sep;82(3):1132-6. |
| D006474 | Hemorrhagic Disorders |